Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with NDAQ: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
NDAQ
Nasdaq, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
NDAQ
Nasdaq, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
AZN
Astrazeneca PLC
Change
186.63
▲
+7.01%
· post 186.35
Mkt cap
$289.5B
Revenue
—
Revenue
—
NDAQ
Nasdaq, Inc.
Change
106.25
▲
+0.61%
· post 106.20
Closed
Oct 30 '26
Mkt cap
$59.0B
Revenue
$2.4B
Q3 FY26
Revenue
$8.3B
FY25
vs
Compare
Closed
Oct 30 '26
AZN
Astrazeneca PLC
vs
NDAQ
Nasdaq, Inc.
186.63
▲
+7.01%
post 186.35
Price
106.25
▲
+0.61%
post 106.20
$289.5B
Mkt cap
$59.0B
—
Revenue
$2.4B
Q3 FY26
—
Revenue
$8.3B
FY25
Change
Change
AZN
186.63
▲
+7.01%
vs
NDAQ
106.25
▲
+0.61%
Closed
Oct 30 '26
Earnings history
last 4 reports each · paired by recency
Method
›
AZN
No earnings history for AZN.
NDAQ
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.2%
▲
+7.47%
×2.34
Q2 FY26
±3.3%
▼
−0.53%
×0.15
Q1 FY26
±3.1%
▲
+0.78%
×0.26
Jan 29 '26
±4.6%
▼
−0.63%
×0.13
= implied
AZN realized, solid
NDAQ realized, hatched
One scale, both sides: full bar = 8%
× = |realized| ÷ implied
Source: market data